![PDF] Tau Protein-Targeted Therapies in Alzheimer's Disease: Current State and Future Perspectives | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d0b824259b25173e952c07d0978554f9e20554dc/7-Table1-1.png "PDF] Tau Protein-Targeted Therapies in Alzheimer's Disease: Current State and Future Perspectives | Semantic Scholar")
PDF] Tau Protein-Targeted Therapies in Alzheimer's Disease: Current State and Future Perspectives | Semantic Scholar
Current Status of Clinical Trials on Tau Immunotherapies | SpringerLink
Pipeline - Tau Consortium
Tau-targeting therapies for Alzheimer disease. - Abstract - Europe PMC
Clinical Trials | TauRx Pharmaceuticals
In DIAN-TU, Gantenerumab Brings Down Tau. By a Lot. Open Extension Planned | ALZFORUM
Research - Tau Consortium
International Alzheimer's clinical trial to test tau drugs – Washington University School of Medicine in St. Louis
Targeting tau: Clinical trials and novel therapeutic approaches - ScienceDirect
Alzheimer's disease: clinical trials and drug development - The Lancet Neurology
ANTI-TAU TRIALS FOR ALZHEIMER'S DISEASE: A REPORT FROM THE EU/US/CTAD TASK FORCE • The Journal of Prevention of Alzheimer's Disease
Tau NexGen Alzheimer's Trial Now Also Testing Anti-Amyloid Treatment
Tau Clinical Trials – What can be learned from failure? - Etap Lab
New Strategy for Clinical Trial Success in Alzheimer Disease – Consult QD
International Alzheimer's clinical trial to test two drugs in combination – Washington University School of Medicine in St. Louis
AC Immune's Tau Vaccine for Alzheimer's Advanced into Phase Ib/II Clinical Trials | BioSpace
Clinical trials of new drugs for Alzheimer disease | Journal of Biomedical Science | Full Text
Aducanumab Treatment in Clinical Trials Lowered Participants' Levels of Potential Blood Biomarker for Alzheimer Disease - Practical Neurology
Vaccination strategies in tauopathies and synucleinopathies - Braczynski - 2017 - Journal of Neurochemistry - Wiley Online Library
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial - The Lancet Neurology
Early Alzheimer's Trajectories May Vary Widely | MedPage Today
Looking Past Amyloid-β: Emerging Alzheimer's Disease Therapies | Lions Talk Science
History and progress of hypotheses and clinical trials for Alzheimer's disease | Signal Transduction and Targeted Therapy
Frontiers | Targeting Tau to Treat Clinical Features of Huntington's Disease | Neurology
